Changes in management of idiopathic pulmonary fibrosis: impact on disease severity and mortality
Background Idiopathic pulmonary fibrosis (IPF) is a serious interstitial lung disease (ILD) with a median survival of 3-5 years. The aim of the present study was to evaluate disease severity and survival in patients diagnosed with IPF in the era of antifibrotic therapies compared with an earlier IPF...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | European Clinical Respiratory Journal |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20018525.2020.1807682 |